泛素特异性蛋白酶14作为肿瘤分子生物标志的研究进展

Research advance on ubiquitin-specific protease 14 as novel carcinogenesis biomarker

  • 摘要: 不良的环境以及职业因素会导致包括肿瘤在内的疾病高发,需要特异的与环境应激相关的分子生物标志来指导疾病的诊断和治疗。近些年来,泛素特异性蛋白酶14(USP14)逐渐引起了研究者的关注。USP14广泛表达于机体的各种器官中,调控着多种信号通路中重要蛋白质的稳定与降解。研究表明,其异常表达与肿瘤、神经系统变性疾病、自噬、免疫应答和病毒感染高度相关,参与调控多种经典的信号传导通路,被证明在人类多种疾病发生发展中起关键作用,可以作为肿瘤发生发展中的诊断和预后分子生物标志物及治疗靶点。本文综述了目前关于USP14结构、调控及其在生理和病理过程中的功能的研究现状,以及USP14靶向药物的发展,以期为环境与职业因素所致疾病或损伤的研究提供参考依据。

     

    Abstract: Hazardous environmental factors as well as occupational factors can lead to elevated incidence of diseases including tumors, and specific molecular biomarkers are needed to guide the diagnosis and treatment of diseases. In recent years, ubiquitin-specific protease 14 (USP14) has gradually attracted the attention of researchers. USP14 is widely expressed in various organs of human body and regulates the stability and degradation of important proteins in various signaling pathways. Studies have shown that its abnormal expression is highly correlated with tumors, neurodegenerative diseases, autophagy, immune response, and viral infections, and is involved in the regulation of various classic signaling pathways. It has been shown to play a key role in the development of various human diseases and can be used as a diagnostic and prognostic molecular biomarker and therapeutic target in the development of tumors. This paper reviewed the current status of research on the structure and regulation of USP14 and its function in physiological and pathological processes, with the aim of providing a reference for research on diseases or injuries caused by environmental and occupational factors.

     

/

返回文章
返回